The Chronic Rhinosinusitis Integrative Research Program (CRISP) is focused on significantly moving forward the field of research on chronic rhinosinusitis (CRS) by proposing novel and exciting approaches integrating Epidemiology, Genetics and Immunology. The PI of Core A is Dr. Robert Schleimer, who is assisted by Ms Valarie Thomas and Ms Jennifer Felten, two senior administrators at the Northwestern University Feinberg School of Medicine. The primary purposes ofthe Administrative Core A are to: provide central administrative services for CRISP and the participating centers;to facilitate communications among the investigators of CRISP and convene Advisory Boards;to assure the dissemination of discoveries made by CRISP investigators;to promote the training of young investigators to pursue CRS research;and to promote the synergies that result from interdisciplinary collaborations. Since the Projects of CRISP are situated in three distinct sites and represent three distinct disciplines, we will have quarterly meetings of all CRISP participating investigators. Two annual meetings will convene in Chicago and two will utilize videoconference technology. We will have an Internal Advisory Board meeting every year and an External Advisory Board every year. We will structure internet-based data sharing facilities, including a HIPAA compliant REDCap system and a hosted password protected website. We will mount a CRISP website for the use ofthe public and investigators of CRISP. Core A will be responsible for all fiduciary and reporting duties associated with the grant. We will innovate a grant program for MD or PhD students or fellows to promote interest in pursuing careers in CRS. CRISP will also play an important role in mentoring junior faculty with the same interests. Core A will monitor transfers of clinical samples and associated data among the participating centers managed by Core B, the Clinical, Laboratory and Data Management Core. Core A will assure the fulfillment of duties by Core B and the CRISP Projects. The PI of Core A will insure that the three Projects of CRISP, and the investigators in distinct disciplines that make them up, strive to capture the utmost ofthe synergies that can be realized from this highly integrative and collaborative project.

Public Health Relevance

CRISP consists of three Projects and two Cores, and is geared toward a deeper understanding ofthe epidemiology, genetics and pathogenesis of chronic rhinosinusitis, a disease that affects tens of millions of Americans. Core A will supervise the entire research program and assume administrative responsibility for the budget, publication process, advisory board meetings and educational program. Most importantly. Core A will promote synergy and integrate the research efforts among investigators in CRISP

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Program Projects (P01)
Project #
1P01AI106683-01
Application #
8592188
Study Section
Special Emphasis Panel (ZAI1-LAR-I (M2))
Project Start
Project End
Budget Start
2013-08-05
Budget End
2014-07-31
Support Year
1
Fiscal Year
2013
Total Cost
$82,163
Indirect Cost
$14,840
Name
Northwestern University at Chicago
Department
Type
DUNS #
005436803
City
Chicago
State
IL
Country
United States
Zip Code
60611
Hirsch, A G; Stewart, W F; Sundaresan, A S et al. (2017) Nasal and sinus symptoms and chronic rhinosinusitis in a population-based sample. Allergy 72:274-281
Lidder, Alcina K; Detwiller, Kara Y; Price, Caroline P E et al. (2017) Evaluating metrics of responsiveness using patient-reported outcome measures in chronic rhinosinusitis. Int Forum Allergy Rhinol 7:128-134
Min, Jin-Young; Ocampo, Christopher J; Stevens, Whitney W et al. (2017) Proton pump inhibitors decrease eotaxin-3/CCL26 expression in patients with chronic rhinosinusitis with nasal polyps: Possible role of the nongastric H,K-ATPase. J Allergy Clin Immunol 139:130-141.e11
Van Roey, Griet A; Vanison, Christopher C; Wu, Jeffanie et al. (2017) Classical complement pathway activation in the nasal tissue of patients with chronic rhinosinusitis. J Allergy Clin Immunol 140:89-100.e2
Ogasawara, Noriko; Poposki, Julie A; Klingler, Aiko I et al. (2017) IL-10, TGF-?, and glucocorticoid prevent the production of type 2 cytokines in human group 2 innate lymphoid cells. J Allergy Clin Immunol :
Ghadersohi, Saied; Tan, Bruce K (2017) Contemporary Pharmacotherapy for Allergic Rhinitis and Chronic Rhinosinusitis. Otolaryngol Clin North Am 50:1135-1151
Igartua, Catherine; Davenport, Emily R; Gilad, Yoav et al. (2017) Host genetic variation in mucosal immunity pathways influences the upper airway microbiome. Microbiome 5:16
Schleimer, Robert P (2017) Immunopathogenesis of Chronic Rhinosinusitis and Nasal Polyposis. Annu Rev Pathol 12:331-357
Nicodemus-Johnson, Jessie; Myers, Rachel A; Sakabe, Noburu J et al. (2016) DNA methylation in lung cells is associated with asthma endotypes and genetic risk. JCI Insight 1:e90151
Bose, Sumit; Grammer, Leslie C; Peters, Anju T (2016) Infectious Chronic Rhinosinusitis. J Allergy Clin Immunol Pract 4:584-9

Showing the most recent 10 out of 49 publications